IRIS
AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.264
EU - Europa 984
NA - Nord America 870
SA - Sud America 169
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 818
SG - Singapore 531
HK - Hong Kong 303
IT - Italia 303
CN - Cina 197
RU - Federazione Russa 152
BR - Brasile 143
DE - Germania 128
IE - Irlanda 95
GB - Regno Unito 71
VN - Vietnam 65
ID - Indonesia 54
SE - Svezia 37
CA - Canada 28
BJ - Benin 27
FI - Finlandia 26
UA - Ucraina 26
ES - Italia 25
KR - Corea 23
FR - Francia 22
MX - Messico 19
IN - India 18
PL - Polonia 18
CZ - Repubblica Ceca 16
NL - Olanda 16
AT - Austria 14
TR - Turchia 12
AR - Argentina 10
CH - Svizzera 10
JP - Giappone 9
IQ - Iraq 8
LT - Lituania 8
PK - Pakistan 8
BD - Bangladesh 7
ZA - Sudafrica 6
BE - Belgio 5
MY - Malesia 5
EC - Ecuador 4
IL - Israele 4
VE - Venezuela 4
GR - Grecia 3
IR - Iran 3
RO - Romania 3
AU - Australia 2
BG - Bulgaria 2
CO - Colombia 2
EG - Egitto 2
HR - Croazia 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MA - Marocco 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.327
Salva come PNG Salva come JPEG
Città #
Hong Kong 302
Singapore 212
Beijing 112
Ashburn 109
Dublin 95
Milan 55
Los Angeles 54
Jakarta 43
New York 42
Turin 42
Munich 41
Novara 32
Jacksonville 30
Cotonou 27
Boardman 26
São Paulo 23
Buffalo 21
Vercelli 21
Frankfurt am Main 18
Moscow 18
Warsaw 18
Ho Chi Minh City 17
Seoul 17
Brno 16
Chandler 16
Nuremberg 16
London 15
Manchester 15
Brooklyn 14
Atlanta 13
Dearborn 13
Hanoi 13
Falkenstein 12
Poplar 12
Santa Clara 12
Stockholm 12
Denver 11
Helsinki 11
Rome 11
Amsterdam 10
Chennai 10
Mexico City 10
Ankara 9
Orem 9
Phoenix 9
Tokyo 9
Dallas 8
Montreal 8
San Francisco 8
Vienna 8
Chicago 7
Toronto 7
Bologna 6
Borgomanero 6
Brasília 6
Houston 6
Lawrence 6
Princeton 6
Rio de Janeiro 6
Wilmington 6
Biên Hòa 5
Boston 5
Guarulhos 5
Petaling Jaya 5
San Mateo 5
Tianjin 5
Zurich 5
Baghdad 4
Bexley 4
Como 4
Johannesburg 4
Las Vegas 4
Rawalpindi 4
Redondo Beach 4
Turku 4
Valencia 4
Alessandria 3
Andover 3
Arapongas 3
Athens 3
Bari 3
Beauharnois 3
Belo Horizonte 3
Bern 3
Brussels 3
Calgary 3
City of London 3
Curitiba 3
Irvington 3
Kunming 3
Magenta 3
Mascalucia 3
Mülheim 3
Palo Alto 3
Phủ Lý 3
Piemonte 3
Querétaro 3
Raleigh 3
Roubaix 3
Truccazzano 3
Totale 1.890
Salva come PNG Salva come JPEG
Nome #
Bi-directional crosstalk between NAD/NAMPT and IFN-γ/PD-L1axes in melanoma 116
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 104
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 102
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 100
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 90
NAMPT in drug-resistant melanoma: linking NAMPT-dependent metabolic reprogramming and immune regulation 86
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma 81
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 79
The Extracellular NADome Modulates Immune Responses 79
NAMPT inhibition impairs mTOR-dependent regulation of translation in melanomaNAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma. 77
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 74
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms 73
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 70
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 64
Investigating the presence of eNAMPT/visfatin in human skimmed milk and milk fat globule membrane before and after Holder pasteurization. 61
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 60
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 56
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network 56
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 56
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 53
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 53
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 51
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 51
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 50
Impact of Holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk 50
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 49
The hidden life of NAD+-consuming ectoenzymes in the endocrine system 49
Procedimento immunologico e kit per la diagnosi in vitro di patologie tumorali e/o infiammatorie 48
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 46
Immunological method and kit for in vitro diagnosis of tumor and/or inflammatory diseases 45
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 44
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 43
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 42
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 42
NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment 41
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 40
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 38
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES 38
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 37
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 37
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 35
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 35
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 34
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 34
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle 34
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 31
CD38 in chronic lymphocytic leukemia: from bench to bedside? 31
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 30
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 30
NAMPT: A critical driver and therapeutic target for cancer 30
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 30
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 29
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 28
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 27
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 26
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 25
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets" 24
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 24
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 24
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia 24
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 24
null 23
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 23
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 23
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 23
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 22
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics 22
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 22
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 21
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 20
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting 20
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options 20
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model 19
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 19
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 19
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 18
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 18
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 17
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 16
Editorial: Metabolic reprogramming in cancer 11
Effects of Ether Perfluoro Carboxyl Acids (PFECAs) on Innate Immunity in Earthworms (Eisenia fetida) 7
Totale 3.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 5 1 5 0 5 0
2021/202228 0 0 4 1 1 0 2 2 1 5 4 8
2022/2023197 6 5 7 2 3 17 3 12 119 6 9 8
2023/2024389 13 26 32 18 62 4 86 33 6 5 22 82
2024/20251.346 46 5 119 34 92 54 177 91 456 53 56 163
2025/20261.349 167 153 171 403 416 39 0 0 0 0 0 0
Totale 3.423